KemPharm Inc at the RBC Capital Markets 2017 Global Healthcare (Replay)
02/22/17 at 9:00 a.m. ET
KemPharm uses its LAT platform technology to discover and develop prodrugs that improve one or more of the attributes of approved drugs, such as susceptibility to abuse, bioavailability and safety.
|Recent News||More >>|
|Upcoming Events||More >>|
|Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources|